Per Departemen/Prodi

Id	Idscopus	Nama	Namabergelar	Departemen	Program Studi	Title	Authors	Source Title	Sjr Best Quartile
Display # Page 32 of 60 Start Prev 27 28 29 30 31 32 33 34 35 36 Next End
ILSI Southeast Asia symposium: prevalence, risk factors, and actions to address gestational diabetes in selected Southeast Asian countries(1)
No records
275						ILSI Southeast Asia symposium: prevalence, risk factors, and actions to address gestational diabetes in selected Southeast Asian countries	Amarra M.S., Chong M.F.-F., Titapant V., Somprasit C., Rogacion J., Irwinda R., Huynh T.N.K., Nalliah S.	European Journal of Clinical Nutrition	Q1	View
Immunogenicity and efficacy of insulin glargine biosimilar ezelin versus originator insulin glargine in patients with type 2 diabetes(3)
No records
210	36057746500	Tri Juli Edi Tarigan	dr. Tri Juli Edi Tarigan, Sp.P.D.(K).	Departemen Ilmu Penyakit Dalam	Ilmu Penyakit Dalam (Sp-1)	Immunogenicity and efficacy of insulin glargine biosimilar ezelin versus originator insulin glargine in patients with type 2 diabetes	Tarigan T.J.E., Dwijayanti A., Setyowati S., Louisa M.	Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy	Q2	View
210	41461551400	Melva Louisa	Dr. Melva Louisa, S.Si., M.Biomed.	Departemen Farmakologi dan Terapeutik	Ilmu Biomedik (S3)	Immunogenicity and efficacy of insulin glargine biosimilar ezelin versus originator insulin glargine in patients with type 2 diabetes	Tarigan T.J.E., Dwijayanti A., Setyowati S., Louisa M.	Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy	Q2	View
210	55743787900	Adisti Dwijayanti	dr. Adisti Dwijayanti, M.Biomed.	Departemen Ilmu Farmasi Kedokteran	Pendidikan Dokter (S1)	Immunogenicity and efficacy of insulin glargine biosimilar ezelin versus originator insulin glargine in patients with type 2 diabetes	Tarigan T.J.E., Dwijayanti A., Setyowati S., Louisa M.	Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy	Q2	View
Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges(2)
No records
218	57190963547	Kaka Renaldi	dr. Kaka Renaldi, Sp.P.D-KGEH.	Departemen Ilmu Penyakit Dalam	Ilmu Penyakit Dalam (Sp-1)	Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges	Suryana K.D., Simadibrata M., Renaldi K.	Acta medica Indonesiana	Q3	View
218	23499598400	Marcellus Simadibrata	Prof. dr. Marcellus Simadibrata, Ph.D., Sp.PD(K).	Departemen Ilmu Penyakit Dalam	Ilmu Penyakit Dalam (Sp-1)	Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges	Suryana K.D., Simadibrata M., Renaldi K.	Acta medica Indonesiana	Q3	View
Impact of the coronavirus disease 2019 pandemic on irritable bowel syndrome(1)
No records
297	8443384400	Ari Fahrial Syam	Prof. Dr. dr. Ari Fahrial Syam, SpPD-KGEH., MMB	Departemen Ilmu Penyakit Dalam	Ilmu Penyakit Dalam (Sp-1)	Impact of the coronavirus disease 2019 pandemic on irritable bowel syndrome	Quek S.X.Z., Loo E.X.L., Demutska A., Chua C.E., Kew G.S., Wong S., Lau H.X., Low E.X.S., Loh T.L., Lung O.S., Hung E.C.W., Rahman M.M., Ghoshal U.C., Wong S.H., Cheung C.K.Y., Syam A.F., Tan N., Xiao Y., Liu J.-S., Lu F., Chen C.-L., Lee Y.Y., Maralit R.M., Kim Y.-S., Oshima T., Miwa H., Pang J., Siah K.T.H.	Journal of Gastroenterology and Hepatology (Australia)	Q1	View
Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI)(3)
No records
42	8651025300	Renan Sukmawan	dr. Renan Sukmawan, S.T., Sp.JP., Ph.D.	Departemen Kardiologi dan Kedokteran Vaskular	Kardiologi dan Kedokteran Vaskular (Sp-1)	Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI)	Sukmawan R., Hoetama E., Suridanda Danny S., Giantini A., Listiyaningsih E., Gilang Rejeki V., Aziz Alkatiri A., Firdaus I.	Pharmacology Research and Perspectives	Q1	View
42	12776781400	Astuti Giantini	dr. Astuti Giantini, Sp.PK	Departemen Patologi Klinik	Patologi Klinik (Sp-1)	Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI)	Sukmawan R., Hoetama E., Suridanda Danny S., Giantini A., Listiyaningsih E., Gilang Rejeki V., Aziz Alkatiri A., Firdaus I.	Pharmacology Research and Perspectives	Q1	View
42	55796864700	Isman Firdaus	dr. Isman Firdaus, Sp.J.P.	Departemen Kardiologi dan Kedokteran Vaskular	Kardiologi dan Kedokteran Vaskular (Sp-1)	Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI)	Sukmawan R., Hoetama E., Suridanda Danny S., Giantini A., Listiyaningsih E., Gilang Rejeki V., Aziz Alkatiri A., Firdaus I.	Pharmacology Research and Perspectives	Q1	View

42

8651025300

Renan Sukmawan

dr. Renan Sukmawan, S.T., Sp.JP., Ph.D.

Departemen Kardiologi dan Kedokteran Vaskular

Kardiologi dan Kedokteran Vaskular (Sp-1)

Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI)

Sukmawan R., Hoetama E., Suridanda Danny S., Giantini A., Listiyaningsih E., Gilang Rejeki V., Aziz Alkatiri A., Firdaus I.

Pharmacology Research and Perspectives

Q1

42

12776781400

Astuti Giantini

dr. Astuti Giantini, Sp.PK

Departemen Patologi Klinik

Patologi Klinik (Sp-1)

Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI)

Sukmawan R., Hoetama E., Suridanda Danny S., Giantini A., Listiyaningsih E., Gilang Rejeki V., Aziz Alkatiri A., Firdaus I.

Pharmacology Research and Perspectives

Q1

42

55796864700

Isman Firdaus

dr. Isman Firdaus, Sp.J.P.

Departemen Kardiologi dan Kedokteran Vaskular

Kardiologi dan Kedokteran Vaskular (Sp-1)

Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI)

Sukmawan R., Hoetama E., Suridanda Danny S., Giantini A., Listiyaningsih E., Gilang Rejeki V., Aziz Alkatiri A., Firdaus I.

Pharmacology Research and Perspectives

Q1

Publikasi Scopus Per Dept/Prodi, 299 artikel (Per 30 April 2021)